Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4766-4772

  Woo, Edward Y ^a   Chu, Christina S ^a   Goletz, Theresa J ^a   Schlienger, Katia ^a   Yeh, Heidi ^a   Coukos, George ^a   Rubin, Stephen C ^a   Kaiser, Larry R ^a   June, Carl H ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LUNG NON SMALL CELL CANCER; OVARY CANCER; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, CD3; ANTIGENS, CD4; CARCINOMA, NON-SMALL-CELL LUNG; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM STAGING; OVARIAN NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035874949     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Reversal of tumor-induced immunosuppression: A new approach to cancer therapy
2. Alterations in T cells of cancer-bearers: Whence specificity?
3. Tumor-induced immune dysfunction
4. T Cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases
5. Gr-l+ myeloid cells derived from tumor-bearing mice inhibit primary T-cell activation induced through CD3/CD28 costimulation
6. CD4+CD25+ immunoregulatory T cells suppress polyclonal T-cell activation in vitro by inhibiting interleukin 2 production
7. + immunoregulatory T cells that control autoimmune diabetes
8. Regulatory T cells: Key controllers of immunologic self-tolerance
9. Loss of T-cell receptor ζ chain and p56lck in T cells infiltrating human renal cell carcinoma
10. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma
11. Signaling defects in T lymphocytes of patients with malignancy
12. + T cells in the absence of exogenous feeder cells
13. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 ζ, the signaling chain of the T-cell receptor complex
14. The CD2-LFA-3 and LFA-1-ICAM pathways: Relevance to T-cell recognition
15. VLA proteins in the integrin family: Structures, functions, and their role on leukocytes
16. Adhesion receptors of the immune system
17. CD69 and regulation of the immune function
18. A lack of evidence for downmodulation of CD3 ζ expression in colorectal carcinoma and pregnancy using multiple detection methods
19. PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR ζ expression but are functionally impaired
20. Absent or low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma
21. Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules
22. Regulatory T cells in autoimmunity
23. CD4(+) T cells prevent spontaneous experimental antoimmune encephalomyelitis in anti-myelin basic protein T-cell receptor transgenic mice
24. Inducing autoimmune disease to treat cancer
25. Effects of TGF-β on the immune system: Implications for cancer immunotherapy
26. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4(+) T cells
27. Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells
28. Bispecific antibody-mediated immunotherapy of the BCL 1 lymphoma: Increased efficacy with multiple injections and CD28-induced costimulation
29. High expression of adhesion molecules/activation markers with little interleukin-2, interferon γ, and tumor necrosis factor β gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma
30. Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small cell lung carcinoma
31. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma
32. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells
33. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumor specimens, peritoneal exudate cells containing tumor, tumor-infiltrating lymphocyte (TIL)-derived T-cell lines, and established tumor cell lines
34. Down-regulation of CD25 expression on the surface of activated tumor- infiltrating lymphocytes in human cervical carcinoma
35. Inhibition of interleukin-2 receptor (CD25) expression induced on T cells from children with acute lymphoblastic leukemia
36. Phenotypic and functional characteristics of mononuclear cells in ovarian carcinoma tumors
37. Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors
38. T-cell unresponsiveness in vivo and in vitro: Fine specificity of induction and molecular characterization of the unresponsive state
39. T cell clonal anergy